Treatment of retinitis pigmentosa due to MERTK mutations by ocular subretinal injection of adeno-associated virus gene vector: results of a phase I trial

Human Genetics
Nicola G GhaziFowzan S Alkuraya

Abstract

MERTK is an essential component of the signaling network that controls phagocytosis in retinal pigment epithelium (RPE), the loss of which results in photoreceptor degeneration. Previous proof-of-concept studies have demonstrated the efficacy of gene therapy using human MERTK (hMERTK) packaged into adeno-associated virus (AAV2) in treating RCS rats and mice with MERTK deficiency. The purpose of this study was to assess the safety of gene transfer via subretinal administration of rAAV2-VMD2-hMERTK in subjects with MERTK-associated retinitis pigmentosa (RP). After a preclinical phase confirming the safety of the study vector in monkeys, six patients (aged 14 to 54, mean 33.3 years) with MERTK-related RP and baseline visual acuity (VA) ranging from 20/50 to <20/6400 were entered in a phase I open-label, dose-escalation trial. One eye of each patient (the worse-seeing eye in five subjects) received a submacular injection of the viral vector, first at a dose of 150 µl (5.96 × 10(10)vg; 2 patients) and then 450 µl (17.88 × 10(10)vg; 4 patients). Patients were followed daily for 10 days at 30, 60, 90, 180, 270, 365, 540, and 730 days post-injection. Collected data included (1) full ophthalmologic examination including best-corrected V...Continue Reading

References

Apr 1, 1985·The British Journal of Ophthalmology·G A FishmanP Lourenco
Jun 1, 1993·Archives of Ophthalmology·E L BersonW Willett
Mar 4, 2000·Human Molecular Genetics·P M D'CruzD Vollrath
Oct 11, 2001·Proceedings of the National Academy of Sciences of the United States of America·D VollrathM M LaVail
May 3, 2003·Nature Reviews. Genetics·Clare E ThomasMark A Kay
Mar 24, 2004·Investigative Ophthalmology & Visual Science·Tomas S AlemanArtur V Cideciyan
Nov 23, 2006·Lancet·Dyonne T HartongThaddeus P Dryja
Apr 29, 2008·The New England Journal of Medicine·Albert M MaguireJean Bennett
Apr 29, 2008·The New England Journal of Medicine·James W B BainbridgeRobin R Ali
Apr 29, 2008·The New England Journal of Medicine·Joan W Miller
Aug 14, 2009·The New England Journal of Medicine·Artur V CideciyanSamuel G Jacobson
Mar 10, 2010·Nature Reviews. Genetics·Alan F WrightShomi S Bhattacharya
Apr 7, 2010·Progress in Retinal and Eye Research·Wolfgang BergerJohn Neidhardt
Apr 14, 2010·Archives of Ophthalmology·Eliot L BersonErnst J Schaefer
May 25, 2011·The Journal of Clinical Investigation·Manzar AshtariJean Bennett
Jan 24, 2013·Proceedings of the National Academy of Sciences of the United States of America·Artur V CideciyanGustavo D Aguirre
Jan 29, 2013·The Journal of Gene Medicine·Samantha L GinnJo Wixon
Apr 2, 2013·JAMA Ophthalmology·Jessy D DornUNKNOWN gus II Study Group
Apr 27, 2013·Gene·Thomas WirthSeppo Ylä-Herttuala
May 25, 2013·Clinical Genetics·S P DaigerS J Bowne
May 6, 2015·The New England Journal of Medicine·James W B BainbridgeRobin R Ali
Sep 12, 2015·Genetics in Medicine : Official Journal of the American College of Medical Genetics·Nisha PatelFowzan S Alkuraya
Oct 3, 2015·Advances in Experimental Medicine and Biology·Matthew M LaVailDouglas Vollrath

❮ Previous
Next ❯

Citations

May 15, 2016·Human Gene Therapy·Lolita PetitClaudio Punzo
Nov 1, 2016·Human Molecular Genetics·Lijuan ZhangStephen H Tsang
Sep 25, 2016·Ophthalmology·Robert E MacLarenSteven D Schwartz
Jan 31, 2017·Genes·Jesse D SengilloStephen H Tsang
Mar 6, 2018·British Medical Bulletin·Neruban KumaranJames W B Bainbridge
Dec 6, 2017·Journal of Ocular Pharmacology and Therapeutics : the Official Journal of the Association for Ocular Pharmacology and Therapeutics·Rachel R Hartman, Uday B Kompella
Oct 24, 2017·Expert Opinion on Biological Therapy·Nicholas A MoorePeter Bracha
Apr 17, 2018·Human Mutation·Isabelle AudoChristina Zeitz
Nov 9, 2017·Journal of Neurogenetics·Joaquín LetelierJuan R Martínez-Morales
Jul 19, 2018·Ophthalmic Surgery, Lasers & Imaging Retina·Benjamin BakallKendra A Klein
Jul 18, 2017·Human Gene Therapy Methods·Elena Herrera-CarrilloBen Berkhout
Sep 21, 2018·Current Opinion in Pediatrics·Abigail Fahim
Apr 23, 2019·Investigative Ophthalmology & Visual Science·Artur V Cideciyan, Samuel G Jacobson
Apr 13, 2019·International Journal of Molecular Sciences·Shirley Suet Lee DingPooi Ling Mok
Mar 6, 2019·Translational Vision Science & Technology·Ettel BubisYgal Rotenstreich
Feb 2, 2019·The British Journal of Ophthalmology·Mustafa IftikharSyed Mahmood Ali Shah
Jul 12, 2019·Current Eye Research·Jinjing CaoChun Zhang
Dec 21, 2019·Journal of Medical Genetics·Daniela BenatiAlessandra Recchia
Jul 3, 2020·Médecine sciences : M/S·Jean-Baptiste DucloyerMichel Weber
Dec 2, 2017·Ophthalmic Genetics·Imran H YusufRobert E MacLaren
Sep 6, 2020·American Journal of Medical Genetics. Part C, Seminars in Medical Genetics·Cristy A Ku, Mark E Pennesi
Sep 26, 2017·Expert Review of Molecular Diagnostics·Oscar F Chacón-CamachoJuan C Zenteno
May 11, 2018·Retina·Galaxy Y ChoVinit B Mahajan
Jun 2, 2018·The Journal of Clinical Investigation·James E DiCarloStephen H Tsang
Apr 26, 2019·Nature Reviews. Immunology·Greg Lemke
Apr 25, 2019·Annual Review of Genomics and Human Genetics·Akiko MaedaMasayo Takahashi
Aug 14, 2019·Translational Vision Science & Technology·Seungbum KangDaniel Palanker
Jun 21, 2020·Gene Therapy·Anne Louise AskouThomas J Corydon
Nov 20, 2016·American Journal of Medical Genetics. Part C, Seminars in Medical Genetics·Jesse D SengilloStephen H Tsang
Mar 7, 2018·Proceedings of the National Academy of Sciences of the United States of America·Karina E GuziewiczGustavo D Aguirre
Oct 7, 2017·Frontiers in Neuroscience·Killian S HanlonG Jane Farrar
Mar 6, 2019·Proceedings of the National Academy of Sciences of the United States of America·Wenjun XiongConstance L Cepko
Jan 1, 2018·Expert Review of Ophthalmology·Kanmin Xue, Robert E MacLaren
May 8, 2020·International Journal of Retina and Vitreous·Huber M VasconcelosAndreas K Lauer
Jan 13, 2018·Human Gene Therapy·Livia S CarvalhoLuk H Vandenberghe
Aug 9, 2018·BMC Genomics·K BligheC B T Moore

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cell-Type-Specific Viral Vectors (ASM)

Viral vectors are used in biological research and therapy to deliver genetic material into cells. However, the efficiency of viral vectors varies depending on the cell type. Here is the latest research on cell-type-specific viral vectors.

CREs: Gene & Cell Therapy

Gene and cell therapy advances have shown promising outcomes for several diseases. The role of cis-regulatory elements (CREs) is crucial in the design of gene therapy vectors. Here is the latest research on CREs in gene and cell therapy.

Blood Clotting Disorders

Thrombophilia includes conditions with increased tendency for excessive blood clotting. Blood clotting occurs when the body has insufficient amounts of specialized proteins that make blood clot and stop bleeding. Here is the latest research on blood clotting disorders.

AAV-based Gene Therapy

Adeno-associated virus (AAV)-based gene therapy is a biological vector that is being researched to be used as a potential therapeutic option. This gene therapy is designed to insert fragments of DNA into targeted cells to help treat diseases, such as hemophilia a. Discover the latest research on AAV-based gene therapy here.

Cell Signaling by Tyrosine Kinases

Receptor tyrosine kinases (RTKs) are the high-affinity cell surface receptors for many polypeptide growth factors, cytokines, and hormones. RTKs have been shown not only to be key regulators of normal cellular processes but also to have a critical role in the development and progression of many types of cancer. Discover the latest research on cell signaling and RTK here.

Blood Coagulation Signaling Pathways

Coagulation is the process by which a blood clot is formed. This process includes both the formation of a platelet plug as well as a cascade of clotting factors resulting in the formation of fibrin strands. Find the latest research on coagulation signaling pathways here.

Cell-Type Specific Viral Vectors

Viral vectors are used in biological research and therapy to deliver genetic material into cells. However, the efficiency of viral vectors varies depending on the cell type. Here is the latest research on cell-type-specific viral vectors.

Cell-Type-Specific Viral Vectors

Viral vectors are used in biological research and therapy to deliver genetic material into cells. However, the efficiency of viral vectors varies depending on the cell type. Here is the latest research on cell-type-specific viral vectors.